{
  "id": 2375,
  "text": "97.Rose, P.G., et al.Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 97.Rose, P.G., et al.Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "要预测局部晚期宫颈癌患者的无进展生存期、总生存期和盆腔复发率，可以借鉴辨识出的预后因素，并结合放射化疗的效果来进行。通过分析来自NRG肿瘤学/妇科肿瘤学组的随机化试验，建立了相应的列线图工具，这些列线图可以帮助预测疾病的进展和复发情况。\n\n首先，无进展生存期（PFS）可以通过考虑患者的临床特征如肿瘤大小、患者的体力状态、淋巴结的受累情况以及肿瘤组织分型等因素来进行预测。结合这些因素形成的列线图可以帮助临床医生评估个体患者的无进展生存期。\n\n其次，总生存期（OS）的预测则可以通过分析上述相似的临床预后因素，再结合患者在放射化疗中的反应情况来推测。准确的OS预测有助于制定适合患者的治疗方案，提高治疗效果。\n\n最后，对于盆腔复发率的预测，重要的是要关注原发肿瘤的位置和治疗前的病情广泛程度等因素。这些可通过列线图整合将影响复发的因素量化，实现风险的初步评估。\n\n通过这些多方面的预测工具和分析方法，可以制定个性化治疗方案，提高患者的生存几率，并减少复发风险。",
  "query": "根据放射化疗和多个预后因素分析，如何预测局部晚期宫颈癌患者的无进展生存期、总生存期和盆腔复发率？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据放射化疗和多个预后因素分析，如何预测局部晚期宫颈癌患者的无进展生存期、总生存期和盆腔复发率？\n\n<reference text>: 97.Rose, P.G., et al.Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "要预测局部晚期宫颈癌患者的无进展生存期、总生存期和盆腔复发率，可以借鉴辨识出的预后因素，并结合放射化疗的效果来进行。通过分析来自NRG肿瘤学/妇科肿瘤学组的随机化试验，建立了相应的列线图工具，这些列线图可以帮助预测疾病的进展和复发情况。\n\n首先，无进展生存期（PFS）可以通过考虑患者的临床特征如肿瘤大小、患者的体力状态、淋巴结的受累情况以及肿瘤组织分型等因素来进行预测。结合这些因素形成的列线图可以帮助临床医生评估个体患者的无进展生存期。\n\n其次，总生存期（OS）的预测则可以通过分析上述相似的临床预后因素，再结合患者在放射化疗中的反应情况来推测。准确的OS预测有助于制定适合患者的治疗方案，提高治疗效果。\n\n最后，对于盆腔复发率的预测，重要的是要关注原发肿瘤的位置和治疗前的病情广泛程度等因素。这些可通过列线图整合将影响复发的因素量化，实现风险的初步评估。\n\n通过这些多方面的预测工具和分析方法，可以制定个性化治疗方案，提高患者的生存几率，并减少复发风险。"
}